Study of Erlotinib in Combination With Bortezomib

• Status: Completed
• Trial end date: 1969-12-31

Summary

The goal of this clinical research study is to find the highest tolerable dose of Tarceva (erlotinib hydrochloride) that can safely be given in combination with Velcade (bortezomib). The safety of this drug combination will also be studied.

• Phase: Phase 1

Details

• Lead Sponsor: M.D. Anderson Cancer Center
• Treatments: Bortezomib; Erlotinib Hydrochloride